BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 30833271)

  • 1. The Immune Subtypes and Landscape of Squamous Cell Carcinoma.
    Li B; Cui Y; Nambiar DK; Sunwoo JB; Li R
    Clin Cancer Res; 2019 Jun; 25(12):3528-3537. PubMed ID: 30833271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
    Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
    J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
    Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
    Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
    Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
    Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape.
    Xie P; An R; Yu S; He J; Zhang H
    J Transl Med; 2021 Sep; 19(1):398. PubMed ID: 34544424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
    Che Y; Luo Z; Zhang C; Sun N; Gao S; He J
    Int Immunopharmacol; 2020 Oct; 87():106802. PubMed ID: 32745903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy.
    Song Y; Yan S; Fan W; Zhang M; Liu W; Lu H; Cao M; Hao C; Chen L; Tian F; Zhan Y; Cai L; Xing Y
    Front Cell Dev Biol; 2020; 8():550. PubMed ID: 32719796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
    Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
    Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of diffuse lower-grade glioma based on immunological profiling.
    Wu F; Wang ZL; Wang KY; Li GZ; Chai RC; Liu YQ; Jiang HY; Zhai Y; Feng YM; Zhao Z; Zhang W
    Mol Oncol; 2020 Sep; 14(9):2081-2095. PubMed ID: 32392361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types.
    Wilkerson MD; Yin X; Hoadley KA; Liu Y; Hayward MC; Cabanski CR; Muldrew K; Miller CR; Randell SH; Socinski MA; Parsons AM; Funkhouser WK; Lee CB; Roberts PJ; Thorne L; Bernard PS; Perou CM; Hayes DN
    Clin Cancer Res; 2010 Oct; 16(19):4864-75. PubMed ID: 20643781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
    Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
    Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.
    Huang X; Tang T; Zhang G; Liang T
    Mol Cancer; 2021 Mar; 20(1):50. PubMed ID: 33685460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
    Jang HJ; Lee HS; Ramos D; Park IK; Kang CH; Burt BM; Kim YT
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1598-1610.e3. PubMed ID: 31879171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intra-class heterogeneity of immunophenotyping and immune landscape in oesophageal cancer and clinical implications.
    Xie Y; Shi X; Chen Y; Wu B; Gong X; Lu W; Lin W
    Ann Med; 2021 Dec; 53(1):626-638. PubMed ID: 33860722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
    Wang X; Li X; Wang X
    J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications.
    Zhao J; Bao W; Cai W
    Biomed Res Int; 2020; 2020():5981870. PubMed ID: 33102584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating CD39
    Qi Y; Xia Y; Lin Z; Qu Y; Qi Y; Chen Y; Zhou Q; Zeng H; Wang J; Chang Y; Bai Q; Wang Y; Zhu Y; Xu L; Chen L; Kong Y; Zhang W; Dai B; Liu L; Guo J; Xu J
    Cancer Immunol Immunother; 2020 Aug; 69(8):1565-1576. PubMed ID: 32306075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.
    Varn FS; Wang Y; Mullins DW; Fiering S; Cheng C
    Cancer Res; 2017 Mar; 77(6):1271-1282. PubMed ID: 28126714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.